Peginesatide for Maintenance Treatment of Anemia in Hemodialysis and Nondialysis Patients Previously Treated with Darbepoetin Alfa

BACKGROUND AND OBJECTIVES: Peginesatide (Omontys) is a novel, synthetic, PEGylated, peptide-based erythropoiesis-stimulating agent (ESA) that is designed to specifically stimulate the erythropoietin receptor. This study evaluated maintenance of hemoglobin levels in patients after conversion from dar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Fishbane, Steven, Roger, Simon D., Martin, Edouard, Runyan, Grant, O’Neil, Janet, Qiu, Ping, Locatelli, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2013
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3613947/
https://ncbi.nlm.nih.gov/pubmed/23243269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.03440412
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados